MYNRIAH

What this means for you

Registered since 11 Jan 2022. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

79314858

Registration number

6610399

Mark type

Stylized text

Filed

02 Jun 2021

Published for opposition

26 Oct 2021

Registered

11 Jan 2022

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical and biological preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system and for the treatment of inflammatory diseases and disorders; pharmaceutical and biological preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for treatment of gastroenterological diseases and disorders; pharmaceutical and biological preparations for the prevention and treatment of ocular disorders and diseases, for the treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; pharmaceutical and biological preparations, namely, anti-fungal, anti-infective, antiviral and antibiotic preparations

Owner

• NOVARTIS AG, CH
• NOVARTIS AG, CH
• NOVARTIS AG, CH

Prosecution history

• 29 May 2022 — NOTIFICATION PROCESSED BY IB
• 03 May 2022 — FINAL DISPOSITION NOTICE SENT TO IB
• 02 May 2022 — FINAL DISPOSITION PROCESSED
• 10 Feb 2022 — GRANT OF PROTECTION CREATED, TO BE SENT TO IB
• 11 Jan 2022 — REGISTERED-PRINCIPAL REGISTER
• 26 Oct 2021 — PUBLISHED FOR OPPOSITION
• 06 Oct 2021 — NOTICE OF PUBLICATION
• 20 Sept 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 20 Sept 2021 — ASSIGNED TO EXAMINER
• 20 Jul 2021 — APPLICATION FILING RECEIPT MAILED
• 15 Jul 2021 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
• 12 Jul 2021 — LIMITATION FROM ORIGINAL APPLICATION ENTERED
• 01 Jul 2021 — SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB